![]() |
市場調查報告書
商品編碼
2144442
RNA干擾(RNAi)作物保護市場預測至2034年-全球RNAi類型、施用方法、目標害蟲、作物類型、發育階段和區域分析RNA Interference Crop Protection Market Forecasts to 2034 - Global Analysis By RNAi Type, Delivery Method, Target Pest, Crop Type, Development Stage, and Geography |
||||||
根據 Stratistics MRC 預測,全球RNA干擾作物保護市場預計到 2026 年將達到 3 億美元,並在預測期內以 27.6% 的複合年成長率成長,到 2034 年將達到 21 億美元。
RNA干擾(RNA)作物保護是指利用RNA分子選擇性地抑製作物中病蟲害特定基因,進而降低其對植物危害能力的農業技術。此方法可透過基因特異性機制靶向昆蟲、真菌、病毒和其他生物威脅。 RNA產品可透過葉面噴布、植物吸收、種子處理或基因改造作物等方式施用。其高度靶向特異性使其能夠在有效控制病蟲害的同時,減少對有益生物的影響,並降低對廣譜殺蟲劑的依賴。應用領域包括病蟲害防治、病害管理和高價值作物保護。對精準、永續作物保護日益成長的需求正在推動該領域的發展。 RNA製劑、遞送系統、分子生物學和田間穩定性的進步正在提升RNA農業解決方案的商業性潛力。
市場動態
對永續作物保護的需求日益成長
對永續和精準作物保護解決方案日益成長的需求推動了RNA干擾技術的應用,該技術能夠實現物種特異性害蟲防治。對傳統農藥日益嚴格的監管也促進了市場擴張。害蟲對化學農藥抗性的增強促使人們採用具有新型作用機制的農藥。 RNAi遞送和製劑技術的進步正在提高產品的功效。永續農業正成為全球農業系統的主流。
監管不確定性和高昂的開發成本
RNAi農作物保護產品監管方面的不確定性和高昂的研發成本是市場成長的障礙。大眾對RNAi技術的接受度有限,可能會限制其在某些地區的應用。 RNAi遞送和穩定性方面的技術挑戰限制了產品開發。 RNAi的高生產成本可能會限制其商業性可行性。 RNAi產品的法律規範因地區而異。
遞送和製劑技術的創新
RNAi遞送和製劑技術的創新正在創造巨大的成長機會。經濟高效的生產方法的開發提高了商業性可行性。對RNAi研究投入量的增加正在加速產品開發。 RNAi公司與農業公司之間的合作正在擴大市場覆蓋範圍。技術進步不斷提高產品的功效和穩定性。
與傳統農藥和生物農藥的競爭
來自傳統農藥和其他生物來源農作物保護產品的競爭可能會限制RNAi技術的應用。經濟壓力可能會影響農民採用高價值技術的意願。影響RNAi核准的監管變化可能會影響市場發展。消費者對RNAi技術的懷疑態度可能會影響其應用。 RNAi技術的快速發展正在吸引新的參與者,並加劇競爭。
新冠疫情凸顯了建立具有韌性和永續的糧食系統的重要性,並加速了人們對基於RNAi技術的作物保護的興趣。供應鏈中斷對傳統農藥的影響促使人們更加關注替代產品。疫情後,對RNAi研發的投資仍在持續。糧食系統的轉型持續推動創新。消費者對永續作物保護的認知也在不斷提高。
在預測期內,小干擾RNA(siRNA)細分市場預計將佔據最大的市場佔有率。
由於siRNA能夠高度特異性基因靜默,從而實現靶向害蟲防治,預計在預測期內,「小干擾RNA(siRNA)」細分市場將佔據最大的市場佔有率。對物種特異性作物保護日益成長的需求正在推動市場擴張。 siRNA設計和遞送技術的進步正在提高其有效性。完善的研發體係也鞏固了該細分市場的領先地位。 siRNA是作物保護領域應用最廣泛的RNAi類型。
預計在預測期內,葉面噴布領域將呈現最高的複合年成長率。
在預測期內,由於葉面噴布細分市場將呈現最高的成長率。農民對熟悉的施用方法的日益青睞也推動了市場擴張。葉面RNAi製劑的進步提高了其穩定性和吸收率。消費者對便捷施用方法的需求持續成長。葉面噴布是RNAi產品研發的重點領域。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其先進的農業技術應用、強大的研發基礎設施和有利的法規環境。美國擁有許多領先的RNAi公司,並具備成熟的研發能力。農民對永續農業實踐的日益重視正在鞏固該地區的市場領先地位。對農業生物技術投資的不斷成長正在推動該技術在全部區域的普及應用。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於廣袤的農田、日益嚴重的病蟲害抗藥性問題以及永續作物保護技術的廣泛應用。中國、印度和澳洲的RNAi作物保護能力正在不斷提升。對糧食安全的日益關注正在加速市場成長。政府對農業創新的支持也為市場創造了有利的環境。
According to Stratistics MRC, the Global RNA Interference Crop Protection Market is accounted for $0.3 billion in 2026 and is expected to reach $2.1 billion by 2034 growing at a CAGR of 27.6% during the forecast period. RNA Interference Crop Protection encompasses agricultural technologies that use RNA molecules to selectively suppress specific genes in crop pests or pathogens, reducing their ability to damage plants. The approach can target insects, fungi, viruses, or other biological threats through gene-specific mechanisms. RNA-based products may be delivered through foliar applications, plant uptake, seed treatments, or genetically engineered crops. Their high target specificity can support pest management while potentially reducing effects on beneficial organisms and lowering dependence on broad-spectrum pesticides. Applications include insect control, disease management, and protection of high-value crops. Growing demand for precise and sustainable crop protection is supporting development. Advances in RNA formulation, delivery systems, molecular biology, and field stability are improving the commercial potential of RNA-based agricultural solutions.
Market Dynamics
Growing demand for sustainable crop protection
Increasing demand for sustainable, targeted crop protection solutions is driving adoption of RNA interference technologies that offer species-specific pest control. Growing regulatory restrictions on conventional pesticides support market expansion. Rising pest resistance to chemical pesticides drives adoption of novel modes of action. Advances in RNAi delivery and formulation enhance product efficacy. Sustainable agriculture is becoming mainstream across global farming systems.
Regulatory uncertainty and high development costs
Regulatory uncertainty for RNAi-based crop protection products and high development costs present barriers to market growth. Limited public acceptance of RNAi technology may affect adoption in certain regions. Technical challenges in RNAi delivery and stability constrain product development. High costs of RNAi production may limit commercial viability. Regulatory frameworks for RNAi products vary significantly across regions.
Innovation in delivery and formulation technologies
Innovation in RNAi delivery and formulation technologies presents significant growth opportunities. Development of cost-effective production methods is improving commercial viability. Growing investment in RNAi research accelerates product development. Partnerships between RNAi companies and agricultural companies expand market reach. Technology advances continue improving product efficacy and stability.
Competition from conventional and biological pesticides
Competition from conventional pesticides and other biological crop protection products may limit RNAi adoption. Economic pressures may affect farmer willingness to adopt premium technologies. Regulatory changes affecting RNAi approval may impact market development. Consumer skepticism regarding RNAi technology may affect adoption. Rapid growth of RNAi attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted the importance of resilient and sustainable food systems, accelerating interest in RNAi crop protection. Supply chain disruptions affecting conventional pesticide availability increased interest in alternative products. The post-pandemic period has witnessed sustained investment in RNAi research and development. Food system transformation continues driving innovation. Consumer awareness of sustainable crop protection continues growing.
The small interfering RNA segment is expected to be the largest during the forecast period
The small interfering RNA segment is expected to account for the largest market share during the forecast period as siRNA offers highly specific gene silencing for targeted pest control. Growing demand for species-specific crop protection drives market expansion. Advances in siRNA design and delivery improve efficacy. Established research and development support segment leadership. siRNA is the most widely used RNAi type for crop protection.
The foliar spray segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the foliar spray segment is predicted to witness the highest growth rate driven by ease of application and compatibility with existing spraying equipment. Growing farmer preference for familiar application methods supports market expansion. Advances in foliar RNAi formulations improve stability and uptake. Consumer demand for convenient delivery methods continues growing. Foliar spray is a key focus area for RNAi product development.
During the forecast period, the North America region is expected to hold the largest market share owing to advanced agricultural technology adoption, strong research infrastructure, and supportive regulatory environment. The United States hosts major RNAi companies with established research and development capabilities. High farmer awareness of sustainable practices reinforces regional market leadership. Growing investment in agricultural biotechnology drives adoption across the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by large agricultural area, growing pest resistance concerns, and increasing adoption of sustainable crop protection. China, India, and Australia are expanding RNAi crop protection capabilities. Growing food security concerns accelerate market growth. Government support for agricultural innovation creates favorable market environment.
Key players in the market
Some of the key players in the RNA Interference Crop Protection Market include Alnylam Pharmaceuticals, Inc., Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., Bioceres Crop Solutions Corp., AgroSpheres, Inc., GreenLight Biosciences, Precision BioSciences, Inc., Protix B.V., Pairwise, Bioceres Crop Solutions, Provivi, Inc., AgBiome and AgroSpheres.
In February 2026, Corteva, Inc. announced the commercial launch of an RNAi-based seed treatment targeting soil-dwelling insect pests in corn. The product represented one of the first commercially available RNAi crop protection solutions.
In September 2025, Syngenta Group announced a significant breakthrough in RNAi delivery technology enabling enhanced stability and uptake through foliar applications. The innovation was expected to accelerate product development timelines.
In December 2024, Bayer AG launched a research collaboration with leading agricultural universities to develop next-generation RNAi formulations for fungal disease control in cereals. The partnership aimed to accelerate commercialization of RNAi technology.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.